Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction

Journal of Controlled Release

Volumn 207, Issue , 2015, Pages 7-17

  Awada, Hassan K ^a,c   Johnson, Noah R ^a,c   Wang, Yadong ^a,b,c  

^a PA 15260   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Coacervate; Controlled release; Fibrin gel; Growth factors; Myocardial infarction; Therapeutic angiogenesis

Indexed keywords

BIOCHEMISTRY; CARDIOLOGY; CELL PROLIFERATION; SYNCHROTRONS;

COACERVATE; CONTROLLED RELEASE; FIBRIN GELS; GROWTH FACTOR; MYOCARDIAL INFARCTION; THERAPEUTIC ANGIOGENESIS;

BIOACTIVITY;

PLATELET DERIVED GROWTH FACTOR; SODIUM CHLORIDE; VASCULOTROPIN; ANGIOGENIC FACTOR; BECAPLERMIN; DELAYED RELEASE FORMULATION; DRUG CARRIER; DRUG COMBINATION; FIBRIN; GEL; HEPARIN; PLATELET DERIVED GROWTH FACTOR B; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BABOON; CARDIAC MUSCLE; CELL CULTURE; CHEMISTRY; CONVALESCENCE; DELAYED RELEASE FORMULATION; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECTS; FIBROSIS; GEL; HEART LEFT VENTRICLE FUNCTION; HUMAN; KINETICS; MEDICINAL CHEMISTRY; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; SMOOTH MUSCLE CELL; SOLUBILITY; SPRAGUE DAWLEY RAT; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; CHEMOTAXIS; DELAYED-ACTION PREPARATIONS; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG COMBINATIONS; FIBRIN; FIBROSIS; GELS; HEPARIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; KINETICS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; PAPIO; PROTO-ONCOGENE PROTEINS C-SIS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SOLUBILITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR FUNCTION, LEFT;

EID: 84926455846     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.03.034     Document Type: Article

References (73)

1. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, M.J. Blaha, S. Dai, E.S. Ford, C.S. Fox, S. Franco, H.J. Fullerton, C. Gillespie, S.M. Hailpern, J.A. Heit, V.J. Howard, M.D. Huffman, S.E. Judd, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, R.H. Mackey, D.J. Magid, G.M. Marcus, A. Marelli, D.B. Matchar, D.K. McGuire, E.R. Mohler III, C.S. Moy, M.E. Mussolino, R.W. Neumar, G. Nichol, D.K. Pandey, N.P. Paynter, M.J. Reeves, P.D. Sorlie, J. Stein, A. Towfighi, T.N. Turan, S.S. Virani, N.D. Wong, D. Woo, and M.B. Turner Heart disease and stroke statistics-2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
2. K. Kurrelmeyer, D. Kalra, B. Bozkurt, F. Wang, Z. Dibbs, Y. Seta, G. Baumgarten, D. Engle, N. Sivasubramanian, and D.L. Mann Cardiac remodeling as a consequence and cause of progressive heart failure Clin. Cardiol. 21 1998 14 19
3. C. Cochain, K.M. Channon, and J.S. Silvestre Angiogenesis in the infarcted myocardium Antioxid. Redox Signal. 18 2013 1100 1113
4. L. Deveza, J. Choi, and F. Yang Therapeutic angiogenesis for treating cardiovascular diseases Theranostics 2 2012 801 814
5. V.F. Segers, and R.T. Lee Protein therapeutics for cardiac regeneration after myocardial infarction J. Cardiovasc. Transl. Res. 3 2010 469 477
6. F.R. Formiga, E. Tamayo, T. Simon-Yarza, B. Pelacho, F. Prosper, and M.J. Blanco-Prieto Angiogenic therapy for cardiac repair based on protein delivery systems Heart Fail. Rev. 17 2012 449 473
7. H. Hwang, and R.A. Kloner Improving regenerating potential of the heart after myocardial infarction: factor-based approach Life Sci. 86 2010 461 472
8. I. Zachary, and R.D. Morgan Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects Heart 97 2011 181 189
9. W.W. Li, K.E. Talcott, A.W. Zhai, E.A. Kruger, and V.W. Li The role of therapeutic angiogenesis in tissue repair and regeneration Adv. Skin Wound Care 18 2005 491 500 (quiz 501-492)
10. F.M. Chen, M. Zhang, and Z.F. Wu Toward delivery of multiple growth factors in tissue engineering Biomaterials 31 2010 6279 6308
11. H. Chu, and Y. Wang Therapeutic angiogenesis: controlled delivery of angiogenic factors Ther. Deliv. 3 2012 693 714
12. P. Tayalia, and D.J. Mooney Controlled growth factor delivery for tissue engineering Adv. Mater. 21 2009 3269 3285
13. S.E. Epstein, R. Kornowski, S. Fuchs, and H.F. Dvorak Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects Circulation 104 2001 115 119
14. R.J. Lee, M.L. Springer, W.E. Blanco-Bose, R. Shaw, P.C. Ursell, and H.M. Blau VEGF gene delivery to myocardium: deleterious effects of unregulated expression Circulation 102 2000 898 901
15. C. Betsholtz Insight into the physiological functions of PDGF through genetic studies in mice Cytokine Growth Factor Rev. 15 2004 215 228
16. L. Eklund, and B.R. Olsen Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling Exp. Cell Res. 312 2006 630 641
17. P. Carmeliet, and R.K. Jain Molecular mechanisms and clinical applications of angiogenesis Nature 473 2011 298 307
18. P.C. Hsieh, M.E. Davis, J. Gannon, C. MacGillivray, and R.T. Lee Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers J. Clin. Invest. 116 2006 237 248
19. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat. Med. 9 2003 669 676
20. N. Maulik, and M. Thirunavukkarasu Growth factors and cell therapy in myocardial regeneration J. Mol. Cell. Cardiol. 44 2008 219 227
21. Y. Brudno, A.B. Ennett-Shepard, R.R. Chen, M. Aizenberg, and D.J. Mooney Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors Biomaterials 34 2013 9201 9209
22. J.I. Greenberg, D.J. Shields, S.G. Barillas, L.M. Acevedo, E. Murphy, J. Huang, L. Scheppke, C. Stockmann, R.S. Johnson, N. Angle, and D.A. Cheresh A role for VEGF as a negative regulator of pericyte function and vessel maturation Nature 456 2008 809 813
23. J.E. Tengood, R. Ridenour, R. Brodsky, A.J. Russell, and S.R. Little Sequential delivery of basic fibroblast growth factor and platelet-derived growth factor for angiogenesis Tissue Eng. A 17 2011 1181 1189
24. H. Chu, N.R. Johnson, N.S. Mason, and Y. Wang A [polycation:heparin] complex releases growth factors with enhanced bioactivity J. Control. Release 150 2011 157 163
25. H.K. Awada, N.R. Johnson, and Y. Wang Dual delivery of vascular endothelial growth factor and hepatocyte growth factor coacervate displays strong angiogenic effects Macromol. Biosci. 14 2014 679 686
26. R. Vasita, and D.S. Katti Growth factor-delivery systems for tissue engineering: a materials perspective Expert Rev. Med. Devices 3 2006 29 47
27. H. Chu, J. Gao, and Y. Wang Design, synthesis, and biocompatibility of an arginine-based polyester Biotechnol. Prog. 28 2012 257 264
28. H. Chu, C.W. Chen, J. Huard, and Y. Wang The effect of a heparin-based coacervate of fibroblast growth factor-2 on scarring in the infarcted myocardium Biomaterials 34 2013 1747 1756
29. H. Chu, J. Gao, C.W. Chen, J. Huard, and Y. Wang Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis Proc. Natl. Acad. Sci. U. S. A. 108 2011 13444 13449
30. N.R. Johnson, and Y. Wang Controlled delivery of heparin-binding EGF-like growth factor yields fast and comprehensive wound healing J. Control. Release 166 2013 124 129
31. N.R. Johnson, and Y. Wang Controlled delivery of sonic hedgehog morphogen and its potential for cardiac repair PLoS One 8 2013 e63075
32. K.W. Lee, N.R. Johnson, J. Gao, and Y. Wang Human progenitor cell recruitment via SDF-1alpha coacervate-laden PGS vascular grafts Biomaterials 34 2013 9877 9885
33. N.R. Johnson, and Y. Wang Coacervate delivery systems for proteins and small molecule drugs Expert Opin. Drug Deliv. 11 2014 1829 1832
34. K.A. Black, D. Priftis, S.L. Perry, J. Yip, W.Y. Byun, and M. Tirrell Protein encapsulation via polypeptide complex coacervation ACS Macro Lett. 3 2014 1088 1091
35. A.C. Aplin, E. Fogel, P. Zorzi, and R.F. Nicosia The aortic ring model of angiogenesis Methods Enzymol. 443 2008 119 136
36. R.S. Go, and W.G. Owen The rat aortic ring assay for in vitro study of angiogenesis Methods Mol. Med. 85 2003 59 64
37. S. Dobner, D. Bezuidenhout, P. Govender, P. Zilla, and N. Davies A synthetic non-degradable polyethylene glycol hydrogel retards adverse post-infarct left ventricular remodeling J. Card. Fail. 15 2009 629 636
38. S. Ashikari-Hada, H. Habuchi, Y. Kariya, N. Itoh, A.H. Reddi, and K. Kimata Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library J. Biol. Chem. 279 2004 12346 12354
39. I. Freeman, A. Kedem, and S. Cohen The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins Biomaterials 29 2008 3260 3268
40. L. Zangi, K.O. Lui, A. von Gise, Q. Ma, W. Ebina, L.M. Ptaszek, D. Spater, H. Xu, M. Tabebordbar, R. Gorbatov, B. Sena, M. Nahrendorf, D.M. Briscoe, R.A. Li, A.J. Wagers, D.J. Rossi, W.T. Pu, and K.R. Chien Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction Nat. Biotechnol. 31 2013 898 907
41. M.G. Sutton, and N. Sharpe Left ventricular remodeling after myocardial infarction: pathophysiology and therapy Circulation 101 2000 2981 2988
42. H.M. Tsai von Willebrand factor, shear stress, and ADAMTS13 in hemostasis and thrombosis ASAIO J. 58 2012 163 169
43. P. Krishnamurthy, J. Rajasingh, E. Lambers, G. Qin, D.W. Losordo, and R. Kishore IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR Circ. Res. 104 2009 e9 e18
44. X. Hao, A. Mansson-Broberg, P. Blomberg, G. Dellgren, A.J. Siddiqui, K.H. Grinnemo, E. Wardell, and C. Sylven Angiogenic and cardiac functional effects of dual gene transfer of VEGF-A165 and PDGF-BB after myocardial infarction Biochem. Biophys. Res. Commun. 322 2004 292 296
45. H. Hwang, and R.A. Kloner The combined administration of multiple soluble factors in the repair of chronically infarcted rat myocardium J. Cardiovasc. Pharmacol. 57 2011 282 286
46. K. Lee, E.A. Silva, and D.J. Mooney Growth factor delivery-based tissue engineering: general approaches and a review of recent developments J. R. Soc. Interface 8 2011 153 170
47. A.K. Silva, C. Richard, M. Bessodes, D. Scherman, and O.W. Merten Growth factor delivery approaches in hydrogels Biomacromolecules 10 2009 9 18
48. R.R. Chen, E.A. Silva, W.W. Yuen, and D.J. Mooney Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation Pharm. Res. 24 2007 258 264
49. T.P. Richardson, M.C. Peters, A.B. Ennett, and D.J. Mooney Polymeric system for dual growth factor delivery Nat. Biotechnol. 19 2001 1029 1034
50. N.H. Davies, C. Schmidt, D. Bezuidenhout, and P. Zilla Sustaining neovascularization of a scaffold through staged release of vascular endothelial growth factor-A and platelet-derived growth factor-BB Tissue Eng. A 18 2012 26 34
51. X. Hao, E.A. Silva, A. Mansson-Broberg, K.H. Grinnemo, A.J. Siddiqui, G. Dellgren, E. Wardell, L.A. Brodin, D.J. Mooney, and C. Sylven Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction Cardiovasc. Res. 75 2007 178 185
52. E. Ruvinov, J. Leor, and S. Cohen The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction Biomaterials 32 2011 565 578
53. S.H. Shin, J. Lee, K.S. Lim, T. Rhim, S.K. Lee, Y.H. Kim, and K.Y. Lee Sequential delivery of TAT-HSP27 and VEGF using microsphere/hydrogel hybrid systems for therapeutic angiogenesis J. Control. Release 166 2013 38 45
54. Q. Sun, E.A. Silva, A. Wang, J.C. Fritton, D.J. Mooney, M.B. Schaffler, P.M. Grossman, and S. Rajagopalan Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis Pharm. Res. 27 2010 264 271
55. I. Capila, and R.J. Linhardt Heparin-protein interactions Angew. Chem. Int. Ed. Engl. 41 2002 391 412
56. B. Mulloy, and M.J. Forster Conformation and dynamics of heparin and heparan sulfate Glycobiology 10 2000 1147 1156
57. L. Pellegrini Role of heparan sulfate in fibroblast growth factor signalling: a structural view Curr. Opin. Struct. Biol. 11 2001 629 634
58. L. Morbidelli, C.H. Chang, J.G. Douglas, H.J. Granger, F. Ledda, and M. Ziche Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium Am. J. Physiol. 270 1996 H411 H415
59. R. van der Zee, T. Murohara, Z. Luo, F. Zollmann, J. Passeri, C. Lekutat, and J.M. Isner Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium Circulation 95 1997 1030 1037
60. J.P. Cooke, and D.W. Losordo Nitric oxide and angiogenesis Circulation 105 2002 2133 2135
61. J.M. Tang, J.N. Wang, L. Zhang, F. Zheng, J.Y. Yang, X. Kong, L.Y. Guo, L. Chen, Y.Z. Huang, Y. Wan, and S.Y. Chen VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart Cardiovasc. Res. 91 2011 402 411
62. O. Bergmann, R.D. Bhardwaj, S. Bernard, S. Zdunek, F. Barnabe-Heider, S. Walsh, J. Zupicich, K. Alkass, B.A. Buchholz, H. Druid, S. Jovinge, and J. Frisen Evidence for cardiomyocyte renewal in humans Science 324 2009 98 102
63. K. Bersell, S. Arab, B. Haring, and B. Kuhn Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury Cell 138 2009 257 270
64. T. Braun, and S. Dimmeler Breaking the silence: stimulating proliferation of adult cardiomyocytes Dev. Cell 17 2009 151 153
65. B. Kuhn, F. del Monte, R.J. Hajjar, Y.S. Chang, D. Lebeche, S. Arab, and M.T. Keating Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair Nat. Med. 13 2007 962 969
66. J.D. Abbott, Y. Huang, D. Liu, R. Hickey, D.S. Krause, and F.J. Giordano Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury Circulation 110 2004 3300 3305
67. S. Dhingra, A.K. Sharma, R.C. Arora, J. Slezak, and P.K. Singal IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis Cardiovasc. Res. 82 2009 59 66
68. N. Takehara, Y. Tsutsumi, K. Tateishi, T. Ogata, H. Tanaka, T. Ueyama, T. Takahashi, T. Takamatsu, M. Fukushima, M. Komeda, M. Yamagishi, H. Yaku, Y. Tabata, H. Matsubara, and H. Oh Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction J. Am. Coll. Cardiol. 52 2008 1858 1865
69. D.H. Choi, R. Subbiah, I.H. Kim, D.K. Han, and K. Park Dual growth factor delivery using biocompatible core-shell microcapsules for angiogenesis Small 9 2013 3468 3476
70. C.T. Drinnan, G. Zhang, M.A. Alexander, A.S. Pulido, and L.J. Suggs Multimodal release of transforming growth factor-beta1 and the BB isoform of platelet derived growth factor from PEGylated fibrin gels J. Control. Release 147 2010 180 186
71. B. Jiang, B. Akar, T.M. Waller, J.C. Larson, A.A. Appel, and E.M. Brey Design of a composite biomaterial system for tissue engineering applications Acta Biomater. 10 2014 1177 1186
72. J.E. Tengood, K.M. Kovach, P.E. Vescovi, A.J. Russell, and S.R. Little Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis Biomaterials 31 2010 7805 7812
73. H. Zhang, Y.L. Yuan, Z. Wang, B. Jiang, C.S. Zhang, Q. Wang, X.H. Xu, H.Y. Dong, and Z.M. Zhang Sequential, timely and controlled expression of hVEGF165 and Ang-1 effectively improves functional angiogenesis and cardiac function in vivo Gene Ther. 20 2013 893 900